Viewing Study NCT02698657


Ignite Creation Date: 2025-12-24 @ 6:48 PM
Ignite Modification Date: 2025-12-28 @ 12:37 PM
Study NCT ID: NCT02698657
Status: COMPLETED
Last Update Posted: 2024-10-31
First Post: 2016-02-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP5094 Following Multiple Intravenous Doses in Subjects With Rheumatoid Arthritis on Methotrexate
Sponsor: Astellas Pharma Global Development, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module